[Spondylodiscitis and Lactococcus cremoris endocarditis].
O
O
Saidane
I
I
Mahmoud
F
F
Saadi
A
A
Souayah
R
R
Zouari
D000368:Aged; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology; D001915:Braces; D002417:Cattle; D003131:Combined Modality Therapy; D015299:Discitis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology* / Q000628:therapy; D004359:Drug Therapy, Combination; D004697:Endocarditis, Bacterial / Q000150:complications / Q000382:microbiology*; D005260:Female; D005506:Food Contamination; D005839:Gentamicins / Q000627:therapeutic use; D016908:Gram-Positive Bacterial Infections / Q000382:microbiology* / Q000635:transmission; D006801:Humans; D017045:Lactococcus / Q000302:isolation & purification / Q000472:pathogenicity*; D008159:Lumbar Vertebrae / Q000382:microbiology*; D008892:Milk / Q000009:adverse effects / Q000382:microbiology; D015242:Ofloxacin / Q000627:therapeutic use; D061352:Pasteurization; D012293:Rifampin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D015242:Ofloxacin; D012293:Rifampin